We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$98.4B
AUM Growth
+$12.2B
Cap. Flow
+$4.67B
Cap. Flow %
4.75%
Top 10 Hldgs %
7.81%
Holding
4,101
New
656
Increased
1,629
Reduced
1,101
Closed
596

Sector Composition

Rank Sector Weight
1 Technology 13.24%
2 Financials 10.53%
3 Industrials 10.31%
4 Healthcare 10.01%
5 Consumer Discretionary 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBG icon
926
HUB Group
HUBG
$3.01B
$18.7M 0.02%
560,265
+335,871
+150% +$11.3M
ALB icon
927
CALL
Albemarle
ALB
$13.5B
$18.7M 0.02%
298,000
+123,700
+71% +$7.31M
ACWI icon
928
iShares MSCI ACWI ETF
ACWI
$32.6B
$18.7M 0.02%
145,208
-48,811
-25% -$5.85M
TARS icon
929
Tarsus Pharmaceuticals
TARS
$2.56B
$18.6M 0.02%
459,436
+212,592
+86% +$9.57M
PGR icon
930
PUT
Progressive
PGR
$124B
$18.6M 0.02%
69,700
-11,400
-14% -$3.12M
LIVN icon
931
LivaNova
LIVN
$4.3B
$18.6M 0.02%
412,156
-64,878
-14% -$2.68M
GIS icon
932
CALL
General Mills
GIS
$19.2B
$18.5M 0.02%
357,700
+350,100
+4,607% +$19.3M
FCNCA icon
933
First Citizens BancShares
FCNCA
$24.6B
$18.4M 0.02%
9,430
-10,488
-53% -$19M
SNOW icon
934
PUT
Snowflake
SNOW
$92.9B
$18.4M 0.02%
82,400
+12,200
+17% +$2.21M
ITRI icon
935
Itron
ITRI
$3.73B
$18.4M 0.02%
139,518
-137,969
-50% -$15.6M
ETN icon
936
CALL
Eaton
ETN
$157B
$18.3M 0.02%
51,400
+45,800
+818% +$14.1M
STLA icon
937
PUT
Stellantis
STLA
$16.5B
$18.3M 0.02%
1,825,000
+1,075,000
+143% +$10.6M
ULTA icon
938
CALL
Ulta Beauty
ULTA
$20.4B
$18.3M 0.02%
39,100
+2,300
+6% +$951K
B
939
CALL
Barrick Mining
B
$62.2B
$18.1M 0.02%
871,700
-15,700
-2% -$307K
CVS icon
940
PUT
CVS Health
CVS
$137B
$18.1M 0.02%
263,100
-146,900
-36% -$9.63M
DVA icon
941
DaVita
DVA
$15.1B
$18.1M 0.02%
+127,380
New +$18M
QLYS icon
942
Qualys
QLYS
$4.84B
$18.1M 0.02%
126,846
-48,748
-28% -$6.45M
IFF icon
943
International Flavors & Fragrances
IFF
$19.4B
$18.1M 0.02%
246,386
-342,213
-58% -$25.8M
CCJ icon
944
CALL
Cameco
CCJ
$38.3B
$18.1M 0.02%
243,600
-21,300
-8% -$1.14M
PPC icon
945
Pilgrim's Pride
PPC
$6.82B
$18.1M 0.02%
401,546
-155,571
-28% -$7.63M
FRSH icon
946
Freshworks
FRSH
$2.84B
$17.9M 0.02%
1,199,782
+196,264
+20% +$2.83M
SKWD icon
947
Skyward Specialty Insurance
SKWD
$2.45B
$17.9M 0.02%
309,253
-75,653
-20% -$4.36M
WK icon
948
Workiva
WK
$2.94B
$17.9M 0.02%
260,900
+82,564
+46% +$5.68M
MMM icon
949
PUT
3M
MMM
$89B
$17.9M 0.02%
117,300
-21,500
-15% -$3.07M
TPH
950
DELISTED
Tri Pointe Homes
TPH
$17.9M 0.02%
558,794
+22,934
+4% +$704K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2025 Portfolio in Review

As of Q2 2025, Qube Research & Technologies (QRT) held 4,101 positions worth $98.4B, up 14% from $86.2B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.67B of net new capital in Q2 2025, opening 656 new positions and adding to 1,629 existing holdings. Its largest new stake was Bristol-Myers Squibb: 9,752,683 shares worth $451M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $675M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2025 buy was Bristol-Myers Squibb: 9,752,683 shares worth $451M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2025, an estimated $486M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $675M.
  • Qube Research & Technologies (QRT) fully exited Broadcom in Q2 2025, selling an estimated $1.02B.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 7.8% of its $98.4B portfolio in Q2 2025.
  • Qube Research & Technologies (QRT) opened 656 new positions and closed 596 in Q2 2025.
  • Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $98.4B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.